Transmission-selective muscle pathology induced by the active propagation of mutant huntingtin across the human neuromuscular synapse.

"Conflict of interest MM, IF, IH, and DG were employed by Novartis. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision."

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by a Swiss National Science Foundation professorship grant (PP00P3_163937; PP00P3_194806) and a Synapsis foundation—Alzheimer's Research Switzerland ARS grant for principal investigators to EP-V."